Study for Promotion of Health in Recycling Lead

Status Active, not recruiting

Clinical Trial Summary

Study for Promotion of Health in Recycling Lead (SPHERL) is a prospective 2-year follow-up study of lead workers with exposure levels varying between and within individuals. SPHERL addresses to what extent between-subject differences or within-subject changes in lead exposure may have a measurable impact on blood pressure, the cardiovascular system, renal function, the autonomic nervous system, peripheral nervous conduction velocity, and neurocognitive function.

At the beginning of December 2015, 70 participants were included in the study.

Clinical Trial Description

Background

- Whether low-level lead exposure impacts on blood pressure, regulation of the cardiovascular system, glomerular or tubular renal function, sympathetic nervous modulation, peripheral nervous conduction velocity, and neurocognitive function remains uncertain.

Study Population

- SPHERL will enroll 500 lead recycling workers with changing lead exposure, who will be examined at baseline (2014-2015) and followed up at annual intervals for 2 years (2016-2017).

Methods

- Volunteers eligible for the study are (i) new and existing hires without previous occupational lead exposure who will be performing tasks with or without occupational lead exposure and (ii) existing hires with occupational lead exposure who will be transitioning to job tasks without occupational lead exposure within the next 2 years.

- Blood lead concentration will be the main biomarker of exposure.

- The main outcome variables are (i) blood pressure measured conventionally and by ambulatory monitoring, and analyzed as continuous or categorical variable, both cross-sectionally and longitudinally; (ii) indexes of glomerular and tubular renal function, (iii) heart rate variability analyzed in the frequency domain as measure of autonomous sympathetic modulation, (iv) peripheral nerve conductivity, (v) neurocognitive performance, (vi) and quality of life [the EuroQOL five dimensions (EQ-5D) questionnaire].

Expected Outcomes

- Assuming a 4-fold or higher surge in the blood lead concentration, the study is powered to demonstrate over 2 years an acceleration in the age-related rise of systolic blood pressure by 1 to 4 mm Hg or an increase of the coefficient of multiple determination (R2) from 0.22 to 0.24 by adding the change in the blood lead concentration to models relating changes in blood pressure to three other covariables. The longitudinal design of our study complies with the temporality principle of the Bradford-Hill criteria for assessing possible causality between outcomes and exposure. ;

Study Design

Related Conditions & MeSH terms

Occupational Exposure

Clinical Trial Details

NCT number	NCT02243904
Study type	Observational
Source	KU Leuven
Contact
Status	Active, not recruiting
Phase
Start date	August 2015
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05006976` - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study	N/A
Not yet recruiting	`NCT03678519` - Occupational Health Hazards Among Flour Mills Workers
Completed	`NCT02985164` - Radiation Exposure During Endoscopic Retrograde Cholangiopancreatography	Phase 3
Completed	`NCT05507944` - FeNO Hairdressers Pilot
Enrolling by invitation	`NCT05766397` - Prehospital Inhaled Methoxyflurane Non-Clinical Occupational Exposure Study	Phase 4
Completed	`NCT05511896` - Effects of a 60-min Repeated Trunk Flexion Protocol on Trunk Neuromuscular Properties.	N/A
Completed	`NCT03002987` - Active Pregnancy Policy at Work. Greater Wellbeing and Lower Sickness Absence	N/A
Active, not recruiting	`NCT03048630` - Reducing Chemical Exposures in Nail Salons	N/A
Completed	`NCT04591756` - Effectiveness of Respiratory Protection During Simulated Resuscitation: a Prospective Cohort Study	N/A
Completed	`NCT04075279` - Heart at Work Study
Enrolling by invitation	`NCT05651477` - Relationship Between Health Risk and Occupational Exposure of ED
Completed	`NCT05097612` - Evaluation of a Soft Exoskeleton to Support Forward Leaning and Lifting	N/A
Completed	`NCT02661074` - Anisakis Blastocystis Cryptosporidium Fish Prevalence	N/A
Completed	`NCT05811767` - The Esbjerg Cohort - A Cross-sectional Study About Work Ability and Musculoskeletal Pain in 55 to 70 Years Old Workers
Completed	`NCT00342394` - Fungicide Exposure Assessment Among Apple and Peach Farmers in the Argicultural Health Study
Not yet recruiting	`NCT03695302` - Knowledge , Attitude and Practice (KAP) of Fifth Year Undergraduate Dental Students on Post Exposure Prophylaxis
Recruiting	`NCT05849168` - High-Intensity Interval Training to Improve Symptoms of Deployment-Related Respiratory Disease	N/A
Completed	`NCT04879082` - Identification Of Occupational Exposures In Patients With ILD
Recruiting	`NCT06193018` - Ergonomic Effects of Using a Professional Passive Exoskeleton
Not yet recruiting	`NCT06188312` - Occupational Hazards Among Workers of Superphosphate Fertilizer Factory

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Study for Promotion of Health in Recycling Lead — SPHERL

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms